KF
LGND icon

Kopp Funds’s Ligand Pharmaceuticals LGND Stock Holding History

Kopp Funds’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$211K Buy
+6,418
New +$209K 0.1% 59

Other funds holding LGND

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Kopp Funds's LGND Position: Q4 2013 in Review

Kopp Funds opened a new position in Ligand Pharmaceuticals (LGND) in Q4 2013: 6,418 shares worth $211K. The stake represents 0.1% of the portfolio and ranks #59 among its holdings.

165 funds tracked by Wall St. Rank hold LGND as of Q4 2013.

  • Kopp Funds held 6,418 shares of Ligand Pharmaceuticals worth $211K as of Q4 2013.
  • Ligand Pharmaceuticals was a new Kopp Funds position in Q4 2013.
  • Ligand Pharmaceuticals made up 0.1% of Kopp Funds's portfolio in Q4 2013, its #59 holding.
  • 165 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2013.

Based on Kopp Funds's 13F filing for Q4 2013, filed 21 Jan 2014.